Report #2870642

Received Nov 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RVX	ROTAVIRUS (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	UNK	—

Symptoms (1)

Mobility decreased

Symptom narrative

Could not move for twelve hours really; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of mobility decreased in a male patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced mobility decreased (Verbatim: Could not move for twelve hours really). The outcome of the mobility decreased was resolved (duration 12 hrs). It was unknown if the reporter considered the mobility decreased to be related to RSV vaccine. It was unknown if the company considered the mobility decreased to be related to RSV vaccine. Additional Information: GSK Receipt Date: 22-OCT-2025 This case was reported by a patient via interactive digital media. They went and got the RSV shot and patient could not move for twelve hours really.